oncology market

Hypofractionation could expand radiotherapy access for 2.2 million patients

Between 2015 and 2035, the economic benefits of radiotherapy investments range from $278.1b to $365.4b.

Hypofractionation could expand radiotherapy access for 2.2 million patients

Between 2015 and 2035, the economic benefits of radiotherapy investments range from $278.1b to $365.4b.

China emerges as key player in oncology with antibody-drug conjugates surge

It represents 82% of the ADC pipeline in major APAC markets.

What’s driving the global gastric cancer diagnostics market?

One key trend is the integration of molecular diagnostics such as next-generation sequencing.

APAC to record fastest-growing interventional oncology market

There has been an expanding research base across India, China, and Japan.